Tetrapeptide · Fact sheet
Epitalon
Also known as Epithalon · AEDG
Epitalon has changed telomerase activity and telomere length in cell experiments. Those findings do not show that it extends human life, reverses aging, or improves sleep, and it is not FDA approved.
What is Epitalon?
Epitalon is a synthetic four-amino-acid peptide. It should not be treated as interchangeable with epithalamin, a tissue-derived preparation used in some older reports.
Telomeres are chromosome-end structures; changing them in cultured cells is different from improving health in a person.
Benefits people look for
Longevity, sleep regularity, and a younger biological age are the main claims readers encounter. Cell-lifespan findings cannot answer those questions on their own.
What the evidence supports
- A 2003 experiment reported telomerase activation and telomere extension in cultured fibroblasts.
- More recent cell work explored different mechanisms in normal and cancer cell lines; it does not demonstrate a human longevity benefit.
All research areas
- Telomerase activity
- Telomere biology
- Cellular aging
Anecdotal reports & lived experiences
Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens.
Better sleep reported during several simultaneous exposures
A commenter in a DSIP discussion reported less interrupted sleep while also using a product labeled Epithalon and multiple other supplements.
Nothing in this account isolates Epitalon. It provides no evidence of telomere effects, life extension or a stand-alone sleep benefit.
Read the combined-exposure account ↗Side effects & risks
- FDA flags immune-response and impurity concerns and missing route-specific safety information.
- Cell experiments cannot establish long-term cancer safety or quantify adverse effects in people.
This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.
Clinical research: how strong is it?
Mostly animal or lab researchThe cited telomere experiments used cultured human cells, not clinical treatment of people. A 2025 cell-line paper also has a published correction linked in the source record.
Selected research to read
Cell experiment, not a human longevity trial.
Normal and cancer cell experiments; see the linked published correction.
Correction replacing incorrectly published figures 1–3; the original article has been corrected.
FDA approval & research status
Epitalon has no FDA-approved product. Laboratory telomere studies and older reports on related preparations do not document an approved anti-aging treatment.
No FDA-approved use is documented in the records summarized on this page.
No established FDA drug approval path
Epitalon has no FDA-approved product. Laboratory telomere studies and older reports on related preparations do not document an approved anti-aging treatment.
This summarizes the cited product or research record. Trial phases do not establish successful completion of earlier stages, and a stopped program is not ongoing development. Approval applies only to the labeled product, use and population.
What we still don’t know
- Effects on human lifespan or age-related disease
- Reliable sleep outcomes
- Long-term effects on cell growth and cancer risk
The takeaway
Epitalon is an experimental aging research topic, with a large gap between cell findings and demonstrated human outcomes.
Sources & further reading
Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.
- 1fdaFDA: safety concerns for selected bulk substances
Ingredient-specific safety findings; compounding review is not drug approval.
- 2
- 3pubmedEpitalon and telomere length in cell lines
Normal and cancer cell experiments; see the linked published correction.
- 4pubmedCorrection to the 2025 epitalon cell study
Correction replacing incorrectly published figures 1–3; the original article has been corrected.